Trending Topic

< 1 min

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected in the text. In the section “Eplontersen”, the administration schedule should be written as […]

Vias Markides, HRC 2019 – Customisation of Atrial Fibrillation Strategy

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 30th 2019

We spoke to Dr Vias Markides (Royal Brompton & Harefield NHS Foundation Trust, London, UK) at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, for his thoughts on the customisation of atrial fibrillation treatment strategies and whether it is yet achievable in practice.

Speaker’s Disclosures: Vias Markides has a consultancy agreement with Biosense Webster.

Questions:
1. Customisation of atrial fibrillation strategy – is this truly achievable yet? (0:09)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup